Correlation Between Bone Metabolic Markers and Bone Scan in Prostatic Cancer
- 1 February 1997
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 157 (2), 539-543
- https://doi.org/10.1016/s0022-5347(01)65196-6
Abstract
We examined the correlation between bone metabolic markers and bone scintigraphy in prostatic cancer. Osteoblastic and osteoclastic markers, prostate specific antigen (PSA) and bone scans were investigated in 83 specimens from 70 patients with prostatic cancer, including 32 with and 38 without bone metastasis. All markers except for osteocalcin were significantly greater in patients with than without bone metastasis. Pyridinoline cross-linked carboxyterminal telopeptide, an osteoclastic marker, reflected the extent of bone metastasis more accurately than PSA and other bone markers. Pyridinoline cross-linked carboxyterminal telopeptide might assist PSA and bone scintigraphy in monitoring metastatic bone activity of prostatic cancer.Keywords
This publication has 13 references indexed in Scilit:
- Bone metabolic markers in bone metastasesZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancerBritish Journal of Cancer, 1995
- Bone alkaline phosphatase and prostate‐specific antigen in the monitoring of prostate cancerThe Prostate, 1994
- Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorptionJournal of Bone and Mineral Research, 1994
- Prostate Specific Antigen and Bone Scan Correlation in the Staging and Monitoring of Patients with Prostatic CancerBJU International, 1992
- Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myelomaBritish Journal of Cancer, 1992
- Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseBritish Journal of Cancer, 1992
- Disodium Pamidronate Identifies Differential Osteoclastic Bone Resorption in Metastatic Prostate CancerBJU International, 1992
- The flare phenomenon on radionuclide bone scan in metastatic prostate cancerAmerican Journal of Roentgenology, 1984
- Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatographyAnalytical Biochemistry, 1984